XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENTS – RELATED PARTIES (Tables)
9 Months Ended
Sep. 30, 2022
Investments Related Parties  
Investments in Alzamend and Ault & Company at September 30, 2022 and December 31, 2021, were comprised of the following:

Investments in Alzamend and Ault & Company at September 30, 2022 and December 31, 2021, were comprised of the following:

 

Investment in Promissory Notes, Related Parties

 

   Interest  Due  September 30,   December 31, 
   rate  date  2022   2021 
Investment in promissory note of Ault & Company  8%  December 31, 2022  $2,500,000   $2,500,000 
Accrued interest receivable, Ault & Company         318,000    170,000 
Other         -    172,000 
Total investment in promissory note, related party        $2,818,000   $2,842,000 

 

Investment in Common Stock and Options, Related Parties

 

   September 30,   December 31, 
   2022   2021 
Investment in common stock and options of Alzamend  $12,394,000   $13,230,000 
The following table summarizes the changes in the Company’s investments in Alzamend and Ault & Company during the nine months ended September 30, 2022:

The following table summarizes the changes in the Company’s investments in Alzamend and Ault & Company during the nine months ended September 30, 2022:

 

   Investment in
warrants and
common stock of
Alzamend
   Investment in
promissory notes of
Ault & Company
 
Balance at January 1, 2022  $13,230,000   $2,842,000 
Investment in common stock and options of Alzamend   4,840,000    - 
Unrealized loss in common stock of Alzamend   (5,676,000)   - 
Amortization of related party investment   -    (173,000)
Accrued interest   -    149,000 
Balance at September 30, 2022  $12,394,000   $2,818,000 
The following table summarizes the changes in the Company’s investments in Alzamend common stock during the nine months ended September 30, 2022:

The following table summarizes the changes in the Company’s investments in Alzamend common stock during the nine months ended September 30, 2022:

   Shares of   Per Share   Investment in 
   Common Stock   Price   Common Stock 
Balance at January 1, 2022   6,947,000   $1.90   $13,230,000 
March 9, 2021 securities purchase agreement*   2,667,000   $1.50    4,000,000 
Open market purchases after initial public offering   801,000   $1.05    840,000 
Unrealized loss in common stock of Alzamend             (5,676,000)
Balance at September 30, 2022   10,415,000   $1.19   $12,394,000 

 

*Pursuant to the March 9, 2021 securities purchase agreement, in aggregate, Alzamend agreed to sell up to 6,666,667 shares of its common stock to Ault Lending for $10.0 million, or $1.50 per share, and issue to Ault Lending warrants to acquire 3,333,334 shares of Alzamend common stock with an exercise price of $3.00 per share. As of December 31, 2021, Ault Lending funded $6.0 million, including the conversion of notes and advances of $0.8 million, and the remaining $4.0 million was funded upon Alzamend achieving certain milestones during the nine months ended September 30, 2022.